Risk of Second Primary Cancer Among Patients with Cardio-Esophageal Cancer in Finland: A Nationwide Population-Based Study

References

• Sheikh M, Roshandel G, McCormack V, Malekzadeh R. Current status and future prospects for esophageal cancer. Cancers. 2023;15(3):765. doi:10.3390/cancers15030765
   PubMed Web of Science ®Google Scholar
• Larønningen S, Arvidsson G, Bray F, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, version 9.3 (02.10.2023). Association of the Nordic Cancer Registries. Cancer Registry of Norway; 2023. Available from: https://nordcan.iarc.fr/. Accessed June 30, 2024.
   Google Scholar
• Mitani S, Kadowaki S, Oze I, et al. Risk of second primary malignancies after definitive treatment for esophageal cancer: a competing risk analysis. Cancer Med. 2020;9(1):394–400. doi:10.1002/cam4.2688
   PubMed Web of Science ®Google Scholar
• Ha PK, Califano JA. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med. 2003;14(5):363–369. doi:10.1177/154411130301400506
   PubMedGoogle Scholar
• Bugter O, Li Y, Wolters AHG, et al. Early upper aerodigestive tract cancer detection using electron Microscopy to Reveal chromatin packing alterations in buccal mucosa cells. Microsc Microanal. 2021;27(4):878–888. doi:10.1017/S1431927621000507
   PubMed Web of Science ®Google Scholar
• Bunbanjerdsuk S, Vorasan N, Saethang T, et al. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma. Mod Pathol. 2019;32(7):943–956. doi:10.1038/s41379-019-0211-2
   PubMed Web of Science ®Google Scholar
• van de Ven SEM, Falger JM, Verhoeven RHA, et al. Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population. United Eur Gastroenterol J. 2021;9(4):497–506. doi:10.1177/2050640620977129
   PubMed Web of Science ®Google Scholar
• Chen SC, Teng CJ, Hu YW, et al. Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: a nationwide population-based study. PLoS One. 2015;10(1):e0116384. doi:10.1371/journal.pone.0116384
   PubMed Web of Science ®Google Scholar
• Zhu G, Chen Y, Zhu Z, et al. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries. Dis Esophagus. 2012;25(6):505–511. doi:10.1111/j.1442-2050.2011.01273.x
   PubMed Web of Science ®Google Scholar
• Chuang SC, Hashibe M, Scelo G, et al. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev. 2008;17(6):1543–1549. doi:10.1158/1055-9965.EPI-07-2876
   PubMed Web of Science ®Google Scholar
• Ohmori M, Ishihara R, Morishima T, et al. Excessive risk of second-cancer incidence and cancer mortality in patients with esophageal cancer. J Gastroenterol. 2021;56(5):434–441. doi:10.1007/s00535-021-01767-2
   PubMed Web of Science ®Google Scholar
• Marsman WA, Tytgat GNJ, Ten Kate FJW, Van Lanschot JJB. Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction. J Surg Oncol. 2005;92(3):160–168. doi:10.1002/jso.20358
   PubMed Web of Science ®Google Scholar
• Quante M, Wang TC, Bass AJ. Adenocarcinoma of the oesophagus: is it gastric cancer? Gut. 2023;72(6):1027–1029. doi:10.1136/gutjnl-2022-327096
   PubMed Web of Science ®Google Scholar
• Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233(9):780–786. doi:10.1038/s41415-022-5166-x
   PubMed Web of Science ®Google Scholar
• Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48(3):889–902. doi:10.1183/13993003.00359-2016
   PubMed Web of Science ®Google Scholar
• Ning FL, Lyu J, Pei JP, et al. The burden and trend of gastric cancer and possible risk factors in five Asian countries from 1990 to 2019. Sci Rep. 2022;12(1):5980. doi:10.1038/s41598-022-10014-4
   PubMed Web of Science ®Google Scholar
• O’Sullivan DE, Sutherland RL, Town S, et al. Risk factors for early-onset colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022;20(6):1229–1240. doi:10.1016/j.cgh.2021.01.037
   PubMed Web of Science ®Google Scholar
• Von Kroge PR, Bokemeyer F, Ghandili S, Bokemeyer C, Seidel C. The impact of smoking cessation and continuation on recurrence and survival in patients with head and neck cancer: a systematic review of the literature. Oncol Res Treat. 2020;43(10):549–558. doi:10.1159/000509427
   PubMed Web of Science ®Google Scholar
• Do KA, Johnson MM, Doherty DA, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003;14(2):131–138. doi:10.1023/A:1023060315781
   PubMed Web of Science ®Google Scholar
• Mäkelä P, Tigerstedt C, Mustonen H. The Finnish drinking culture: change and continuity in the past 40 years. Drug Alcohol Rev. 2012;31(7):831–840. doi:10.1111/j.1465-3362.2012.00479.x
   PubMed Web of Science ®Google Scholar
• Vartiainen VA, Jousilahti P, Laatikainen T, Vartiainen E. Contribution of smoking change to 45-year trend in prevalence of chronic bronchitis in Finland. Scand J Public Health. 2023;51(8):1189–1195. doi:10.1177/14034948221104351
   PubMed Web of Science ®Google Scholar
• Leinonen MK, Miettinen J, Heikkinen S, Pitkäniemi J, Malila N. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31–39. doi:10.1016/j.ejca.2017.02.017
   PubMed Web of Science ®Google Scholar
• Stuckless S, Parfrey PS. Bias in clinical research. Methods Mol Biol. 2021;2249:17–34.
   PubMedGoogle Scholar